Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Partnership For Self-Care Drug Interaction Package Sent To Pharmacists

This article was originally published in The Tan Sheet

Executive Summary

The Partnership for Self-Care, a consumer education initiative between the American Pharmaceutical Association and McNeil Consumer Healthcare, has begun sending packages to over 50,000 pharmacists containing "the latest scientific review of drug-drug interactions involving OTC medications," prescription pharmaceuticals and dietary supplements.

You may also be interested in...

McNeil, APhA Team Up For Consumer Education On OTC Usage

The distribution of over 50,000 "resource kits" to pharmacists nationwide will kick off a campaign by McNeil Consumer Products and the American Pharmaceutical Association to educate consumers about selecting and using OTCs appropriately, the two parties announced Oct. 27.

In Brief: Women's medicine use

Women's medicine use: Nationwide campaign initiated by FDA to educate women, as families' primary caregivers, about how to use medicines correctly. The grassroots campaign targets women over 45 and will provide information about preventing drug interactions, following directions, keeping track of medication regimens and soliciting professional advice. FDA's Office of Women's Health is working with the National Association of Chain Drug Stores, consumer organizations, women's groups, health care providers, health institutions and government agencies to create the program, which includes brochures in English and Spanish, a 15-city tour and workshops in rural communities and Indian reservations...

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts